News › Clinical Practice, Industry News

Pulse Biosciences Announces Presentation of Clinical Results Using Nano-Pulse Stimulation Technology

October 8, 2020

Pulse Biosciences, Inc., a bioelectric medicine company progressing Nano-Pulse Stimulation (NPS) technology, has announced that clinical results from studies spanning the company’s dermatologic application portfolio will be presented at the American Society for Dermatologic Surgery (ASDS) virtual annual meeting on October 9 – 11, 2020. Positive study results generated using the company’s cellular-specific NPS mechanism performed with its CellFX System for the treatment of sebaceous hyperplasia lesions, cutaneous non-genital warts, plantar warts and basal cell carcinoma will be presented in two oral presentations and two e-posters.
Read more at Business Wire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • AmSpa CEO Reflects on the Sonya Dakar Case
    • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
    • GlossGenius Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • PDGF, Regenerative Medicine and the Questions Med Spas Can’t Ignore
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
Advertisement